Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
11 mai 2023 16h05 HE
|
Vor Biopharma
VBP101 clinical data update planned at European Hematology Association (EHA) 2023VCAR33ALLO IND submission on-track for 1H 2023 CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:...
Be The Match Champions Raise Over $420,000 at 2023 New York Gala to Save More Lives Through Blood Stem Cell Transplants
08 mai 2023 08h47 HE
|
Be The Match
MINNEAPOLIS, May 08, 2023 (GLOBE NEWSWIRE) -- Be The Match Foundation® hosted its annual New York Gala on Thursday, May 4 to raise critical funding that supports patient assistance grants, research...
Global Cancer Monoclonal Antibodies Market Anticipated to Garner $106,825.10 Million, Growing at a 7.0% CAGR in the 2022-2031 Timeframe [260-Pages] | Announced by Research Dive
26 avr. 2023 10h30 HE
|
Research Dive
New York, USA, April 26, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global cancer monoclonal antibodies market. According to the report, the global market is projected...
The International Myeloma Foundation (IMF) Launches Medical Student Scholars for Health Equity in Myeloma Mentoring Program
20 avr. 2023 08h45 HE
|
International Myeloma Foundation
STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a...
Results of Study on Cryopreserved Hematopoietic Stem Cell Grafts By CIBMTR Published in Blood Advances
18 avr. 2023 08h00 HE
|
Be The Match
MINNEAPOLIS, April 18, 2023 (GLOBE NEWSWIRE) -- CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced that the results of a multi-center observational study, around the...
One Community, One Question: What Is Your #MYelomaSTORY?
06 avr. 2023 08h45 HE
|
International Myeloma Foundation
STUDIO CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month (MAM), the International Myeloma Foundation (IMF) was truly grateful for everyone’s...
The International Myeloma Foundation Announces the Annual Miles for Myeloma 5K Run/Walk: 15 Years of Making a Difference in the Myeloma Community
03 avr. 2023 08h45 HE
|
International Myeloma Foundation
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- The Annual Miles for Myeloma Hybrid 5K Run/Walk will once again “Redefine Being Together” on Saturday, April 29, virtually and in-person at FDR Park...
National Marrow Donor Program/Be The Match Continues to Invest in Researchers of Tomorrow and Expands its Philanthropically Funded Research Programs
16 mars 2023 16h08 HE
|
Be The Match
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match® announced two recipients of its Amy Strelzer Manasevit Research Program grant for 2023. The grant...
Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report 2023: A $2.3 Billion Market by 2030 - High Demand for Advanced Medicines and Implementation of International Standards by CROs
24 févr. 2023 06h43 HE
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report By Indication (Blood Cancer, Solid Tumor), By Region, And Segment Forecasts,...
International Myeloma Foundation (IMF) Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023
23 févr. 2023 08h45 HE
|
International Myeloma Foundation
STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to...